Geniride MP 2mg/500mg/15mg Tablet SR
Marketer
Levenr Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Geniride MP 2mg/500mg/15mg Tablet SR
Combirelin-D 2mg/500mg/15mg Extended-Release Tablets are a multi-component medication designed to manage blood glucose. This medication, used in conjunction with a balanced diet and regular exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates efficient insulin use, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combirelin-D 2mg/500mg/15mg Extended-Release Tablets. Taking it with food minimizes gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be conducted prior to treatment initiation. Limit alcohol consumption as it may heighten the risk of side effects.
Uses of Geniride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Geniride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Geniride MP 2mg/500mg/15mg Extended-Release tablet should be taken with meals.
Common Side effects of Geniride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Geniride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Geniride MP 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Take this extended-release tablet with food.
How Geniride MP 2mg/500mg/15mg Tablet SR works:
Geniride MP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Geniride MP 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Geniride MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Geniride MP 2mg/500mg/15mg SR tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Geniride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. For those with severe kidney disease, this medication is contraindicated. Consult your physician. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Geniride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Geniride MP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Geniride MP 2mg/500mg/15mg Tablet SR :
Should you forget a Geniride MP 2mg/500mg/15mg Tablet SR dose, take it promptly. However, near the time for your next dose, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Geniride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently